<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01654848</url>
  </required_header>
  <id_info>
    <org_study_id>TransplanTUM-1</org_study_id>
    <secondary_id>HITafterOLT</secondary_id>
    <nct_id>NCT01654848</nct_id>
  </id_info>
  <brief_title>Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients</brief_title>
  <acronym>HITOLT</acronym>
  <official_title>Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHIR-Net</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CHIR-Net</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a prospective observational study the incidence of Heparin-induced Thrombocytopenia (HIT)
      Type 2 after orthotopic liver transplantation, associated factors, and hemostaseological
      findings in thrombocytes and anti-body patterns is going to be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators examined the frequency of anti-PF4/heparin antibodies (IgG/M/A; EIA) and
      their functional activity (HIPA) in 38 whole organ deceased donor liver transplant
      recipients. Additionally, demographic, clinical, donor- and recipient-specific parameters and
      laboratory findings (ALAT, ASAT, cholinesterase) were investigated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">39</enrollment>
  <condition>Heparin-induced Thrombocytopenia</condition>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>orthotopic Liver Transplantation</arm_group_label>
    <description>consecutive inclusion of all recipients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive livertransplant recipients of our transplant center, organ allocation via
        Eurotransplant Foundation, Leiden, The Netherlands; Laboratory investigations performed at
        the Abteilung f체r Transfusionsmedizin am Institut f체r Immunologie und Transfusionsmedizin
        der Universit채tsmedizin Greifswald, Greifswald, Germany
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all consecutive liver transplant recipients between 01/2010 and 08/2011 who

          -  were transplanted at our center after allocation of a liver graft via Eurotransplant

        Exclusion Criteria:

          -  patient's refusal to participate in prospective observation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Assfalg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum rechts der Isar, Dept. of Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der TU M체nchen</name>
      <address>
        <city>Munich</city>
        <zip>D-81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2012</study_first_submitted>
  <study_first_submitted_qc>July 31, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <last_update_submitted>July 31, 2012</last_update_submitted>
  <last_update_submitted_qc>July 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>thrombocytes</keyword>
  <keyword>heparin-induced thrombocytopenia</keyword>
  <keyword>multivariate analysis of associated factors of HIT 2 after OLT</keyword>
  <keyword>laboratory investigations of HIT-antibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombocytopenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

